Lexon × Jeff Koons Unveil the Chromatic Collection: a Colorful New Chapter for the Acclaimed Balloon Dog Lamp and Balloon Dog Speaker March 24, 2026 Eight new models introduce vibrant color variations, expanding the collection’s appeal to new and existing collectors alike.
Clinical Healthcare Analytics Forges Transatlantic Partnership with St. Vincent’s Consulting March 24, 2026 Combining frontline clinical analytics with NHS digital transformation expertise creates a uniquely global, outcomes-driven offering for healthcare leaders
Xsolla and Stevenage FC Launch Charity Campaign With SpecialEffect to Make Gaming Accessible for All March 24, 2026 Donation Of 50 Accessible Setups Reinforces Xsolla’s Commitment To Inclusive Gaming
viagogo Announces Partnership with ULTRA Europe to Expand Global Access to Europe’s Premier Destination Festival March 24, 2026 New collaboration supports ULTRA’s international growth strategy, reaching new fans worldwide and strengthening ticket access across Europe
Sytel Reply Named Zuora’s 2025 EMEA RSI Partner of the Year Enabling Value-Based Monetization for AI March 24, 2026 Sytel Reply, the Reply Group company specialized in subscription management, billing transformation and revenue management platforms, has been recognized by Zuora as its 2025 EMEA RSI Partner of the Year for its expertise in Zuora implementation and strategic consulting in monetization across the EMEA region. This press release features multimedia. View the full release here: [...]
Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal March 24, 2026 Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026 Special Committee Determines that Victory Capital’s Revised Unsolicited March 17, 2026 Proposal Is Not Actionable and Is Not in Best Interests of Janus Henderson and Its Shareholders Amended Merger Agreement’s All-Cash Transaction With Trian and General Catalyst Is Superior From an Expected Value and Certainty Perspective and Is the Only Actionable Proposal
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model March 24, 2026 Partnership will integrate ICON’s clinical trial technology with Advarra’s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation.
Kaplan Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 for AI-Powered Educational Products March 24, 2026 Kaplan has been recognized as one of the World’s Most Innovative Companies of 2026 by Fast Company. This award highlights Kaplan’s leadership in artificial intelligence (AI) across three key areas: personalized admissions counseling, adaptive independent study, and scalable technical feedback. Summary of Kaplan’s AI Innovations: AI College Admissions Tool: KapAdvisor™ Premium for Parents reduces family [...]
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028
TPG and Allianz Lead USD 350 Million Strategic Investment in Cambridge Mobile Telematics to Accelerate AI-Driven Road Safety March 24, 2026 Partnership to Expand Global Road Safety Platform and Real-Time AI Risk Models Accompanied by New Long-Term Commercial Agreements Between Allianz and CMT
